Literature DB >> 29136793

Electrochemical monitoring of the interaction between anticancer drug and DNA in the presence of antioxidant.

Merve Muti1, Mihrican Muti2.   

Abstract

The aim of this work is to find out the effect of antioxidant onto the interaction of DNA-anticancer drug, daunorubicin. Daunorubicin (DNR) is an anti-cancer drug which is used for the treatment of certain cancers including the treatment of leukemia. The treatments of patients, who suffer from cancer, become generally complicated if they take some antioxidant-containing supplement during chemotherapy. In this study, the interaction performance between DNR and DNA was investigated both in the presence and absence of antioxidant, caffeic acid, as the first time in the literature. Interaction performances were evaluated by observing both guanine (1.0V) and DNR (0.5V) oxidation signal in the same potential window.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antioxidant; Caffeic acid; Daunorubicin; Drug-DNA interaction; Electrochemistry

Mesh:

Substances:

Year:  2017        PMID: 29136793     DOI: 10.1016/j.talanta.2017.08.089

Source DB:  PubMed          Journal:  Talanta        ISSN: 0039-9140            Impact factor:   6.057


  3 in total

1.  Detection of Imatinib Based on Electrochemical Sensor Constructed Using Biosynthesized Graphene-Silver Nanocomposite.

Authors:  Zhen Wu; Jingjing Liu; Minmin Liang; Haoyue Zheng; Chuansheng Zhu; Yan Wang
Journal:  Front Chem       Date:  2021-04-22       Impact factor: 5.221

2.  Probing the Intercalation of Noscapine from Sodium Dodecyl Sulfate Micelles to Calf Thymus Deoxyribose Nucleic Acid: A Mechanistic Approach.

Authors:  Neha Maurya; Khalid Ahmed Alzahrani; Rajan Patel
Journal:  ACS Omega       Date:  2019-09-17

3.  Redox Mechanism of Azathioprine and Its Interaction with DNA.

Authors:  Mihaela-Cristina Bunea; Victor-Constantin Diculescu; Monica Enculescu; Horia Iovu; Teodor Adrian Enache
Journal:  Int J Mol Sci       Date:  2021-06-24       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.